Almirall SA Almirall Ord Shs (0O9B) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Sep 2024 11:45 AM
BZW
New Data Show Almirall´s EBGLYSS® (Lebrikizum...
23 Sep 2024 11:09 AM
BZW
Almirall to Present New Data on Biologics for...
22 Jul 2024 06:10 AM
BZW
Almirall’s H1 2024 Results: Almirall Delivers...
10 Jul 2024 07:14 AM
BZW
NICE Recommends Ebglyss (lebrikizumab) for Us...
02 Jul 2024 12:52 PM
BZW
Almirall Launches Act4Impact – its Updated Su...
28 Jun 2024 01:30 PM
BZW
Almirall’s Ilumetri® (tildrakizumab) Restores...
13 May 2024 06:16 AM
BZW
Almirall Delivers Strong Start of 2024 – Q1 N...
13 Mar 2024 03:33 PM
BZW
Almirall and Eloxx Pharmaceuticals Enter into...
19 Feb 2024 06:20 AM
BZW
Almirall Licenses an Anti-IL-21 Monoclonal An...
19 Feb 2024 06:02 AM
BZW
Almirall continues its progress to leadership...
21 Dec 2023 11:01 AM
BZW
Almirall Initiates First Phase I Clinical Stu...
12 Dec 2023 07:25 AM
BZW
Almirall and etherna Enter Into a Multi-Targe...
17 Nov 2023 11:02 AM
BZW
Almirall Receives European Commission Approva...
14 Nov 2023 07:16 AM
BZW
Almirall and Absci announce AI drug discovery...
09 Nov 2023 06:28 AM
BZW
Almirall’s Nine-month 2023 Results:
20 Oct 2023 11:45 AM
BZW
Almirall: Nearly 80% of patients with moderat...
13 Oct 2023 10:00 AM
BZW
Almirall's Lebrikizumab Improves Signs and Sy...
11 Oct 2023 10:05 AM
BZW
Almirall's Ilumetri® (tildrakizumab) Signific...
24 Jul 2023 06:32 AM
BZW
Almirall’s H1 2023 Results: Almirall Achieves...
07 Jul 2023 11:26 AM
BZW
Almirall: Ilumetri® (tildrakizumab) significa...
20 Jun 2023 08:13 AM
BZW
Almirall launches Nina, the first series to h...
13 Jun 2023 07:15 AM
BZW
Almirall announces the pricing and closing of...
12 Jun 2023 06:31 PM
BZW
Almirall Announces the Launch of a €200mm Non...
08 May 2023 06:18 AM
BZW
Almirall’s First Quarter 2023 Results
01 May 2023 10:45 AM
BZW
Almirall: Up to 73% of Atopic Dermatitis Pati...
UK 100

Latest directors dealings